menu
    • menu

    Company profile for ClostraBio

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ​ClostraBio has completed numerous supportive nonclinical studies to validate our CLB-004 program. The company has transferred our manufacturing process to a CDMO where we've successfully manufactured multiple kg-scale batches of material for nonclinical studies. With IND-enabling toxicology studies underway, we expect to initiate a clinical study in ~12 months. Given the expected favorable safety profile of our compounds,...
    ​ClostraBio has completed numerous supportive nonclinical studies to validate our CLB-004 program. The company has transferred our manufacturing process to a CDMO where we've successfully manufactured multiple kg-scale batches of material for nonclinical studies. With IND-enabling toxicology studies underway, we expect to initiate a clinical study in ~12 months. Given the expected favorable safety profile of our compounds, we intend to enroll patients with mild-moderate ulcerative colitis UC in a Phase 1a/b SAD-MAD clinical study to obtain safety/tolerability data, determine our Phase 2 dose, and generate exploratory efficacy endpoints.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ClostraBioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1375 West Fulton Street, Suite 650, Chicago, IL 60607
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://clostrabio.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/clostrabio-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ClostraBio Launch with DFH, Starts CLB101 Study, Join SupplySide
    ClostraBio Launch with DFH, Starts CLB101 Study, Join SupplySide

    23 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251023058714/en/ClostraBio-Announces-Commercial-Launch-with-Designs-for-Health-Initiation-of-Clinical-Study-for-CLB101-and-Participation-in-SupplySide-Global

    BUSINESSWIRE
    23 Oct 2025
    Share Share
    Designs For Health Launches Anaerostipes Probiotic For Gut Health
    Designs For Health Launches Anaerostipes Probiotic For Gut Health

    24 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/designs-for-health-introduces-revolutionary-gut-health-supplement-anaerostipes-probiotic-302565952.html

    PR NEWSWIRE
    24 Sep 2025
    Share Share
    ClostraBio Appoints Scott Ravech to Board, Releases CLB101
    ClostraBio Appoints Scott Ravech to Board, Releases CLB101

    16 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-16/clostrabio-announces-key-milestones-board-appointment-of-industry-veteran-scott-ravech-and-publicat

    PHARMAWEB
    16 Sep 2025
    Share Share
    ClostraBio Gains GRAS Status for Probiotic Ingredient CLB101
    ClostraBio Gains GRAS Status for Probiotic Ingredient CLB101

    29 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250729574134/en/ClostraBio-Inc.-Obtains-Self-Affirmed-GRAS-Status-for-Next-Gen-Probiotic-Ingredient-CLB101

    BUSINESSWIRE
    29 Jul 2025
    Share Share
    ClostraBio Gains INVENT Illinois Funds, Plans 2025 Launch
    ClostraBio Gains INVENT Illinois Funds, Plans 2025 Launch

    20 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250320781307/en/ClostraBio-Gains-INVENT-Illinois-Investment-Appoints-New-CSO-Announces-Plans-for-First-Product-Launch-in-Summer-2025

    BUSINESSWIRE
    20 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search